IP Library Granted Patent US 8,951,769
Granted Patent B2
US 8,951,769 · App. 13/265,533 · Granted Feb 10, 2015

Engineered demeter 5-methylcytosine DNA glyosylase with improved yield, stability and solubility

Inventors: Jin Hoe Huh (Davis, CA); Robert Fischer (El Cerrito, CA)
Assignee: The Regents of the University of California
C12Q1/6844C12N9/2434C12N9/2497
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,951,769
App. No.
13/265,533
Granted
Feb 10, 2015
Kind
B2
Abstract

Improved active DEMETER polypeptides with internal deletions are provided.

Claims (19)

1. An isolated polypeptide consisting of:

a first amino acid sequence, wherein the first amino acid sequence is at least 90% identical to the amino acid sequence of SEQ ID NO: 1,

a second amino acid sequence, wherein the second amino acid sequence is at least 90% identical to the amino acid sequence of SEQ ID NO: 2, and

optionally a linker, wherein the linker consists of 1-300 amino acids,

wherein the first and second amino acid sequences are linked directly or by the linker and wherein the polypeptide excises methylated cytosines in DNA when contacted to DNA comprising methylated cytosines.

2. The polypeptide of claim 1 , wherein the first and second amino acid sequences are linked directly.

3. The polypeptide of claim 1 , wherein the first and second amino acid sequences are linked by the linker.

4. The polypeptide of claim 3 , wherein the linker is heterologous to the first or second amino acid sequence.

5. The polypeptide of claim 3 , wherein the linker consists of 10-300 amino acids of the amino acid sequence of SEQ ID NO: 3.

6. The polypeptide of claim 3 , wherein the linker consists of 20 or fewer amino acids.

7. The polypeptide of claim 3 , wherein the linker consists of the amino acid sequence of SEQ ID NO: 4.

8. The polypeptide of claim 1 , wherein the first amino acid sequence is at least 95% identical to the amino acid sequence of SEQ ID NO: 1.

9. The polypeptide of claim 1 , wherein the second amino acid sequence is at least 95% identical to the amino acid sequence of SEQ ID NO: 2.

10. The polypeptide of claim 1 , wherein the first amino acid sequence consists of the amino acid sequence of SEQ ID NO: 1 and the second amino acid sequence consists of the amino acid sequence of SEQ ID NO: 2.

11. A method of making the polypeptide of claim 1 , the method comprising, culturing an isolated cell under conditions to allow for expression of the polypeptide of claim 1 , wherein the isolated cell comprises an expression cassette, the expression cassette comprising a promoter operably linked to a polynucleotide encoding the polypeptide of claim 1 thereby making the polypeptide of claim 1 .

12. The method of claim 11 , further comprising purifying the polypeptide.

13. The method of claim 11 , wherein the cell is a eukaryotic cell.

14. The method of claim 13 , wherein the cell is a yeast, fungal, mammalian or insect cell.

15. The method of claim 11 , wherein the cell is a prokaryotic cell.

Assignments (2)
CONFIRMATORY LICENSE Recorded Aug 21, 2012
From: UNIVERSITY OF CALIFORNIA BERKELEY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 028820/0103 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 3, 2012
From: HUH, JIN HOE; FISCHER, ROBERT
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 027472/0293 →
Continuity (2)
Provisional Application 61170978 · Apr 20, 2009
Related Publication 20120149023A1 · Jun 14, 2012